Article
A P(V)-Platform for Oligonucleotide Synthesis
2021-04-13
Abstract excerpt
The early promise of gene-based therapies is currently being realized at an accelerated pace with over 155 active clinical trials for antisense compounds and multiple FDA-approved oligonucleotide therapeutics. Fundamental advances in this area are vital and present an unprecedented opportunity to both address disease states that have been resistant to other common modalities and improve the significant sustainabil...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cb7b93d5-caf3-5acf-894a-002ebcce96a0
- DOI
- 10.26434/chemrxiv.14403488.v1
